A multi-parameter, high-content, high-throughput screening platform to identify natural compounds that modulate insulin and Pdx1 expression
- PMID: 20886041
- PMCID: PMC2944895
- DOI: 10.1371/journal.pone.0012958
A multi-parameter, high-content, high-throughput screening platform to identify natural compounds that modulate insulin and Pdx1 expression
Abstract
Diabetes is a devastating disease that is ultimately caused by the malfunction or loss of insulin-producing pancreatic beta-cells. Drugs capable of inducing the development of new beta-cells or improving the function or survival of existing beta-cells could conceivably cure this disease. We report a novel high-throughput screening platform that exploits multi-parameter high-content analysis to determine the effect of compounds on beta-cell survival, as well as the promoter activity of two key beta-cell genes, insulin and pdx1. Dispersed human pancreatic islets and MIN6 beta-cells were infected with a dual reporter lentivirus containing both eGFP driven by the insulin promoter and mRFP driven by the pdx1 promoter. B-score statistical transformation was used to correct systemic row and column biases. Using this approach and 5 replicate screens, we identified 7 extracts that reproducibly changed insulin and/or pdx1 promoter activity from a library of 1319 marine invertebrate extracts. The ability of compounds purified from these extracts to significantly modulate insulin mRNA levels was confirmed with real-time PCR. Insulin secretion was analyzed by RIA. Follow-up studies focused on two lead compounds, one that stimulates insulin gene expression and one that inhibits insulin gene expression. Thus, we demonstrate that multi-parameter, high-content screening can identify novel regulators of beta-cell gene expression, such as bivittoside D. This work represents an important step towards the development of drugs to increase insulin expression in diabetes and during in vitro differentiation of beta-cell replacements.
Conflict of interest statement
Figures




Similar articles
-
An siRNA screen in pancreatic beta cells reveals a role for Gpr27 in insulin production.PLoS Genet. 2012 Jan;8(1):e1002449. doi: 10.1371/journal.pgen.1002449. Epub 2012 Jan 12. PLoS Genet. 2012. PMID: 22253604 Free PMC article.
-
A whole organism small molecule screen identifies novel regulators of pancreatic endocrine development.Development. 2019 Jul 24;146(14):dev172569. doi: 10.1242/dev.172569. Development. 2019. PMID: 31142539 Free PMC article.
-
Maturation of adult beta-cells revealed using a Pdx1/insulin dual-reporter lentivirus.Endocrinology. 2009 Apr;150(4):1627-35. doi: 10.1210/en.2008-1224. Epub 2008 Dec 18. Endocrinology. 2009. PMID: 19095744
-
A PDX1-ATF transcriptional complex governs β cell survival during stress.Mol Metab. 2018 Nov;17:39-48. doi: 10.1016/j.molmet.2018.07.007. Epub 2018 Aug 1. Mol Metab. 2018. PMID: 30174228 Free PMC article.
-
PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration.Stem Cell Res Ther. 2017 Nov 2;8(1):240. doi: 10.1186/s13287-017-0694-z. Stem Cell Res Ther. 2017. PMID: 29096722 Free PMC article. Review.
Cited by
-
Bioactive Phytochemicals Isolated from Akebia quinata Enhances Glucose-Stimulated Insulin Secretion by Inducing PDX-1.Plants (Basel). 2020 Aug 24;9(9):1087. doi: 10.3390/plants9091087. Plants (Basel). 2020. PMID: 32847055 Free PMC article.
-
A novel dual-color reporter for identifying insulin-producing beta-cells and classifying heterogeneity of insulinoma cell lines.PLoS One. 2012;7(4):e35521. doi: 10.1371/journal.pone.0035521. Epub 2012 Apr 18. PLoS One. 2012. PMID: 22530041 Free PMC article.
-
High-Throughput Methods for the Discovery of Small Molecule Modulators of Pancreatic Beta-Cell Function and Regeneration.Assay Drug Dev Technol. 2024 Apr;22(3):148-159. doi: 10.1089/adt.2023.119. Epub 2024 Mar 25. Assay Drug Dev Technol. 2024. PMID: 38526231 Free PMC article. Review.
-
Stem Cell-Derived β Cells: A Versatile Research Platform to Interrogate the Genetic Basis of β Cell Dysfunction.Int J Mol Sci. 2022 Jan 2;23(1):501. doi: 10.3390/ijms23010501. Int J Mol Sci. 2022. PMID: 35008927 Free PMC article. Review.
-
Harnessing Human Pluripotent Stem Cell-Derived Pancreatic In Vitro Models for High-Throughput Toxicity Testing and Diabetes Drug Discovery.Handb Exp Pharmacol. 2023;281:301-332. doi: 10.1007/164_2023_655. Handb Exp Pharmacol. 2023. PMID: 37306817
References
-
- Johnson JD, Luciani DS. Mechanisms of Pancreatic beta-Cell Apoptosis in Diabetes and Its Therapies. Islets of Langerhans. 2010;654:447–462. - PubMed
-
- Trudeau JD, Dutz JP, Arany E, Hill DJ, Fieldus WE, et al. Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? Diabetes. 2000;49:1–7. - PubMed
-
- Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–110. - PubMed
-
- Mathis D, Vence L, Benoist C. Beta-cell death during progression to diabetes. Nature. 2001;414:792–798. - PubMed
-
- Johnson JD. Pancreatic Beta-Cell Apoptosis in Maturity Onset Diabetes of the Young. Canadian Journal of Diabetes. 2007;31:001–008.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical